Read + Share
Amedeo Smart
Independent Medical Education
Kim CH, Hwang IC, Choi HM, Ahn CH, et al. Differential cardiovascular and renal benefits of SGLT2 inhibitors and GLP1 receptor agonists in patients with type 2 diabetes mellitus. Int J Cardiol 2022 Jun 15. pii: S0167-5273(22)00927.PMID: 35716949
Email
LinkedIn
Facebook
Twitter
Privacy Policy